A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT03563716 · COMPLETED
Trial details
- NCT number
- NCT03563716
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-10
- Primary completion
- 2019-06-30
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.